期刊文献+

LM-1685对人肺腺癌细胞A549的放射增敏作用 被引量:1

Radiosensitizing effects of cyclooxygenase.2 selective adenocarcinoma cells
原文传递
导出
摘要 目的 观察环氧合酶-2(COX-2)抑制剂对肺癌细胞的放射增敏作用。方法 COX-2抑制剂LM-1685作用于体外培养的肺癌细胞A549,噻唑蓝(MTT)法检测其对肺癌细胞的抑制效果,克隆形成法检测放射敏感性,流式细胞术检测细胞周期变化。结果COX-2抑制剂LM-1685具有明显的抑制A549细胞增殖的作用,其效应呈时间和剂量依赖性,50μmol/LLM-1685在有或没有IL-1β作用下对A549细胞均有放射增敏作用,其放射增敏比分别为1.12、1.06。50μmol/LLM-1685能去除X射线导致的A549细胞G2/M期阻滞。结论 COX-2抑制剂对肺癌细胞A549具有放射增敏作用,放射增敏机制可能与去除G2/M期阻滞有关。 Objective To investigate the radiosensitizing effects of cyclooxygenase-2 selective inhibitor LM-1685 on A549 cells in vitro. Methods A549 human lung adenocarcinoma cell line was used in this study. Cell growth kinetics was determined using MTT assay. Cell survival was analyzed by clonogenic assay. The change of cell cycle was measured by flow cytometry. Results LM-1685 inhibited the growth of A549 cells, showing a dose-dependent and time-dependent manner. LM-1685 (50 μmol/L), either with or without IL-1β, showed the radiosensitizing effects on A549 cells, and the sensitizing enhancement ratio (SER) was 1.12 and 1.06, respectively. LM-1685 (50 μmol/L) abrogated radiation-induced GflM arrest of the tested A549 cells. Conclusions Cyclooxygenase-2 selective inhibitor can enhance the radiosensitivity of A549 cell line. Abrogation of radiation-induced G2/M arrest could be part of the mechanism.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2008年第4期323-326,共4页 Chinese Journal of Radiological Medicine and Protection
基金 国家自然科学基金资助项目(30470501)
关键词 肺癌 放射治疗 COX-2抑制剂 放射增敏 Lung cancer Radiotherapy COX-2 inhibitor Radiosensitization
  • 相关文献

参考文献13

  • 1Khuri FR, Wu H, Lee J J, et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage Ⅰ non-small cell lung cancer. Clin Cancer Res, 2001, 7(4): 861-867.
  • 2陈延治,李建军,顾菲,王志宇.缺氧对肝癌BEL7402细胞周期及放射敏感性的影响[J].中华肿瘤防治杂志,2006,13(10):737-739. 被引量:10
  • 3乔俏,李光,陈延治,王萍萍,李彬.PKC抑制剂对人胰腺癌细胞的放射增敏效应[J].中华放射医学与防护杂志,2005,25(5):435-436. 被引量:8
  • 4Ryu S, Stein JP, Chung CT, et al. Enhanced apoptosis and radiosensitization by combined 13-cis-retinoic acid and interferonalpha 2a: role of RAR-beta gene. Int J Radiat Oncol Biol Phys, 2001, 51(3): 785-790.
  • 5Soslow RA, Dannenberg A J, Rush D, et al. Cox-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer, 2000, 89 (12) : 2637-2645.
  • 6Pyo H, Choy H, Amorino GP, et al. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyelooxygenase-2. Clin Cancer Res, 2001, 7(10): 2998-3005.
  • 7Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med, 2000, 342(26) : 1946-1952.
  • 8Sheng H, Shao J, Morrow JD, et al. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res, 1998, 58(2) : 362-366.
  • 9Sheng H, Shao J, Kirkland SC, et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest, 1997, 99(9) : 2254-2259.
  • 10Hartwell LH, Kastan MB. Cell cycle control and cancer. Science, 1994, 266(5192) : 1821-1828.

二级参考文献23

  • 1Lowe SW, Bodis S, McClatchey, C, et al. In vitro radiobiological parameters of human sarcoma cell lines. Int J Radiat Oncol Biol Phys,1998,15: 937-942.
  • 2Steven J, Helena J, Sunil A, et al. Decreasing the apoptotic thresholdof tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation. Cancer Res,1997,57: 4340-4347.
  • 3Piao Z, Ui-Tei K, Nagano LI. Participation of intracellular Ca+/Calmodulin and protein kinases in the pathway of apoptosis induced by a Drosphilla cell death gene, reaper. Mol Cell Biol Res Commun, 2001,4:307-312.
  • 4Prajakta A, Malini K, Naresh C. Dose-dependent differential expression of protein kinase C isozymes in mouse lymphocytes after gamma irradiation in vivo and in vitro. Radiat Res, 2003,159:453-457.
  • 5Nixon J, Bishop J, Wilkinson S. The design of biological properties of selective inhibitors of protein kinase C. Second Messenger Systems,1992,20:419-425.
  • 6Hutchison C, Peterson S, Gill S, et al. Global transposon mutagenesis and a minimal mycoplasma genome . Science, 1999,286: 2165-2169.
  • 7Thompson L, Fields A. BetaⅡ protein kinase C is required for the G2/M phase transition of cell cycle. J Biol Chem, 1996 ,271:15045-15053.
  • 8Chmura S, Dolan M, Cha A , et al. In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo. Clin Cancer Res, 2000 , 6: 737-742.
  • 9Carmeliet P,Jain R K.Angiogenesis in cancer and other diseases[J].Nature,2000,407(6801):249-257.
  • 10Dachs G U,Tozer G M.Hypoxia modulated gene expression:angiogenesis,metastasis and therapeutic exploitation[J].Eur J Cancer,2000,36(13 Spec No):1649-1660.

共引文献15

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部